Clik here to view.
Three pharma trends from the 2015 J.P. Morgan Healthcare Conference
I attended the J.P. Morgan Annual Healthcare Conference a few weeks ago. Think of it as the CEO version of SXSW for all things big pharma, biotech, health insurance, health tech and large healthcare...
View ArticleClik here to view.
On Creating a (Healthcare) Whole Bigger than the Sum
platform, noun 1. A raised level surface on which people or things can stand. When I think about a platform, especially in business, I imagine a foundation for building an integrated solution or a...
View ArticleClik here to view.
The Two-Edged Sword of Healthcare Reform for Pharma
The Economist recently published a report on the cost impact of healthcare reform in the US. The data shows that the fundamental idea of bending the cost curve by changing the way healthcare is...
View ArticleClik here to view.
Is Your Doctor an Endangered Species?
I recently attended the American College of Physicians’ (ACP) Internal Medicine Meeting, the annual national conference for internists and primary care physicians. It was well attended and offered a...
View ArticleClik here to view.
Can Innovation Trump Consolidation in Healthcare?
At the ACA party, there are 15 pharma companies standing around a room with only 10 chairs. Which means that when the music stops, five of them are SOL. That’s the future for pharma in a world in which...
View ArticleClik here to view.
Making Pharma “Fit for Purpose”
While in London recently for a series of meetings, I repeatedly heard the English phrase “fit for purpose.” It’s become a cliche for many in England, but I was struck by its syllabic crispness and...
View ArticleClik here to view.
Digital Marketing for Pharma: Just Do It
I don’t want to be overly skeptical about the role of innovation in pharma, particularly in the digital marketing space. But a couple of experiences in the last few weeks have led me to wonder whether,...
View ArticleClik here to view.
Pharma…at the moment of truth
There is a moment of truth between a doctor and patient when a diagnosis is made and a treatment regimen is determined. It might be a routine ailment with a simple standard of care protocol. Or it...
View ArticleClik here to view.
Pharma Marketing: How We Learned to Deliver Confident Counsel
The transformation of closerlook into the firm it is today started simply enough. We realized that we had become what so many agencies strive for, the “trusted advisor” for our clients. But that wasn’t...
View ArticleClik here to view.
Four Unique Strategies for Data in Pharma
A significant share of our business focuses on data. We build and manage marketing data analytics and reporting platforms for pharmaceutical brand leaders. What we’ve learned is that this effort...
View Article